ISSN: 1027-3719
Journal Home
Journal Guideline
International Journal of Tuberculosis and Lung Disease Q1 Unclaimed
International Journal of Tuberculosis and Lung Disease is a journal indexed in SJR in Medicine (miscellaneous) and Infectious Diseases with an H index of 121. It has an SJR impact factor of 0,952 and it has a best quartile of Q1. It is published in English. It has an SJR impact factor of 0,952.
International Journal of Tuberculosis and Lung Disease focuses its scope in these topics and keywords: tuberculosis, rifampicin, susceptibility, probe, xpert, infection, latent, management, manaus, communicationhow, ...
Type: Journal
Type of Copyright:
Languages: English
Open Access Policy:
Type of publications:
Publication frecuency: -
- €
Inmediate OANPD
Embargoed OA- €
Non OAMetrics
0,952
SJR Impact factor121
H Index190
Total Docs (Last Year)775
Total Docs (3 years)4673
Total Refs1228
Total Cites (3 years)420
Citable Docs (3 years)1.59
Cites/Doc (2 years)24.59
Ref/DocOther journals with similar parameters
Nature Biomedical Engineering Q1
Journal of Thoracic Oncology Q1
Annual Review of Clinical Psychology Q1
Lancet Digital Health, The Q1
Journal of Experimental Medicine Q1
Compare this journals
Aims and Scope
Best articles by citations
Age, nutritional status and INH acetylator status affect pharmacokinetics of anti-tuberculosis drugs in children
View moreAn investigation of suspected exogenous reinfection in tuberculosis patients in Kampala, Uganda
View moreValidation of the Mandarin Chinese version of the Leicester Cough Questionnaire in bronchiectasis
View morePermanent employment or public assistance may increase tuberculosis survival among working-age patients in Japan
View moreIn reply to 'False-positive Xpert® MTB/RIF assays in previously treated patients'
View moreYield of culture of Mycobacterium tuberculosis complex in sputum samples transported from tribal areas
View moreResults of rapid and successful integration of HIV diagnosis and care into tuberculosis services in Benin
View moreEvaluation of a novel line-probe assay for genotyping-based diagnosis of Mycobacterium tuberculosis in Thailand
View moreEarly antiretroviral treatment reduces risk of bacille Calmette-Guerin immune reconstitution adenitis
View moreWaterpipe tobacco and cigarette smoking among university students in Jordan
View moreProteobacteria community compositions correlate with bronchiectasis severity
View moreChange in serum CXCL10 levels during anti-tuberculosis treatment depends on vitamin D status [Short Communication]
View moreComparative study of the profiles of tribal and non-tribal tuberculosis patients in a tuberculosis unit of West Bengal, India
View moreThe Industrial Revolution and the decline in death rates from tuberculosis
View moreMolecular detection of Mycobacterium tuberculosis from sputum transported in PrimeStore® from rural settings
View moreEarly bactericidal activity of delamanid (OPC-67683) in smear-positive pulmonary tuberculosis patients
View moreComparison of LTBI treatment regimens for patients receiving anti-tumour necrosis factor therapy
View moreBottom-up or top-down: unit cost estimation of tuberculosis diagnostic tests in India
View moreConcomitant tuberculosis and lung cancer diagnosed by bronchoscopy
View moreImproved latent tuberculosis therapy completion rates in refugee patients through use of a clinical pharmacist
View moreHigh tuberculosis exposure among neonates in a high tuberculosis and human immunodeficiency virus burden setting
View moreStrain diversity of mycobacteria isolated from pulmonary tuberculosis patients at Debre Birhan Hospital, Ethiopia
View morePatterns of pncA mutations in drug-resistant Mycobacterium tuberculosis isolated from patients in South Korea
View moreRMP exposure is lower in HIV-infected TB patients receiving intermittent than daily anti-tuberculosis treatment
View more
Comments